Pharmaceutical province 40 varieties to carry out the volume of procurement.

Pharmaceutical province, with volume procurement officially began on October 10, Shandong Provincial Government Procurement Center issued the "Shandong Province drug centralized belt procurement announcement", and published a list of 40 varieties.
of the Festival (September 30), the Shandong Provincial People's Government issued the Notice on the Issue of the Implementation Plan for the Centralized Belt Purchase of Pharmaceuticals and High-Value Medical Supplies in Shandong Province.
10 days later, Shandong Province announced the relevant varieties, meaning that Shandong, the pharmaceutical province official Xuan, 40 varieties of strip procurement, began to implement.
According to Cypress blue combing, aspirin, nitrobenzene, mettorol, fluorocarbon, omeprazole, reberazole, compound glyphosate, lansolazole, left ammonia chloride equality commonly used varieties are in Shandong this time within the scope of harvesting.
27 of the 40 varieties, 13 oral dosage forms, the proportion of injection forms more than two-thirds, and the second round of national collection mainly oral dosage form, the difference is obvious.
this time Shandong Province's procurement documents officially finalized and official announcement, agreed procurement volume and procurement rules are also determined, widely concerned by the industry.
first year agreed to purchase volume: First, the declaration of enterprises 1 evaluation group.
If the actual selected enterprise accepts the lower decrease in the bargaining rules, the agreed purchase amount shall be 60% of the base calculated by the evaluation group, and if the actual selected enterprise accepts the higher decrease, the agreed purchase amount shall be 70% of the evaluation group's calculation base.
2, declare enterprises 2 and 3 and above the evaluation team.
The actual number of selected enterprises is 1, 60% of the base is calculated for the agreed purchase volume in the first year of the review group, and the actual number of selected enterprises is 2, and 70% of the base is calculated for the agreed purchase amount in the first year of the evaluation group.
the evaluation group does not produce the results of the selection, 50% of the agreed purchase amount calculation base of the review group shall be included in the agreed procurement calculation base of another evaluation group of the same variety.
Two review groups with volume it is understood that Shandong Province this time will be the product evaluation group: the first evaluation group: over-protection patented drugs, consistent evaluation of the evaluation of the preparation, through the quality and efficacy of consistent evaluation of generic drugs, according to the new registration of chemicals approved generic drugs, included in the "China Listed Drugs Listed Listed" drugs and China's domestic production of the United States, the European Union (Germany, France), the United Kingdom, Canada, Australia, Japan certified drugs.
second evaluation group: other imported drugs, domestic imitation drugs.
That is to say, Shandong Province, as a major pharmaceutical province, will be the original research drugs and over-evaluation of drug group volume, to avoid its and unestaigned drugs in the price of vicious competition, but also because of the large procurement volume and have a higher bargaining space, giving enterprises the motivation and confidence to reduce prices, a group of foreign-funded enterprises and over-evaluation of leading enterprises or therefore relieved, will be more actively participate in bidding.
this is true, in the past some provinces, without quality level, the results of the unified collection of over-evaluation and un-evaluated injections have formed a reference and inspiration for other provinces.
Taking Shanxi Province as an example, in May, Shanxi Province Pharmaceuticals Centralized Bidding Procurement Network released the "Shanxi Province Medical Institutions First Batch Drug Group Alliance Centralized Band Procurement Results Announcement", including 21 injection varieties, a total of 17 enterprises were selected.
only a few varieties of injections purchased with a large amount have passed or are considered to have passed a consistent evaluation and have not won the bid in this volume purchase.
Previously, Seber blue has learned that, as a high-risk dosage form, because the injection is directly injected into blood vessels, tissues or organs, rapid absorption, rapid action, especially intravenous injections, drugs directly into the blood circulation to play a drug effect, is a higher risk in clinical use of the dosage form, its research and development and production of technical requirements are more stringent.
The National Drug Adverse Reaction Monitoring Center released the Annual Report on Drug Adverse Reaction Monitoring (2018) shows that intravenous drug administration of adverse reactions/incidents accounted for 60% of the total number of reports, in anti-infective drugs, cardiovascular drugs, anti-tumor drugs and drug-related serious adverse reactions/events in the elderly, the proportion of anti-tumor needles accounted for the largest proportion, as high as 89.5%.
This means that injections, especially drugs with narrow treatment windows, should pay more attention to safety and effectiveness, with rich medical resources and procurement volume of Shandong Province, will be divided into two evaluation groups, high quality and low price are selected, or take this into account.
Shandong Province, pharmaceutical companies and soldiers must compete for doctors, nurses and beds, determine a region's basic medical resources, and where doctors, directly determine where the sales of drugs, DT financial estimates, the supply and demand of physician resources show a clear regional difference, Shanghai, Zhejiang, Jiangsu and Shandong are ranked in the country's thousands of doctors top10, these areas are the soldiers of pharmaceutical companies must compete.
therefore, Shandong Province's purchase of these 40 varieties of belt, will directly affect the market pattern of these cash cattle products, its bargaining rules are also every pharmaceutical company must eat through and figure out the content.
to be selected enterprises to determine: (1) the declaration of enterprises 3 or more evaluation group 1. comprehensive evaluation.
For each variety to enterprise quotations, procurement volume ratio, medical institutions coverage and other factors for comprehensive evaluation, the proportion of points is 60%, 20%, 20%, the three points added to the comprehensive evaluation score (the second evaluation group won the National Science and Technology Progress Award second prize and above drugs plus 0.5 points): 2.
in accordance with the selection price in the evaluation group and the same group of high-priced shortlisted enterprises to bargain, the higher-priced shortlisted enterprises to accept the selected price, the second-place selection of the evaluation group enterprises.
not accept the selected price, it will be treated as a waiver.
(2) to declare the enterprise 2 of the evaluation group 1, comprehensive review.
To the proportion of procurement volume, medical institutions coverage rate for comprehensive evaluation, the proportion of points is 20%, 20%, the two points added to the comprehensive evaluation score (the second evaluation group won the second prize of the National Science and Technology Progress Award and above drugs plus 0.5 points): 2, bargaining.
the expert group and the reporting enterprise in the order of the comprehensive evaluation score from highest to low.
Enterprises with higher scores meet the following two conditions, determined to be the first to be selected enterprises, the bargaining price for the evaluation group in the selection of prices, can not be achieved, as abandoned: (1) the price reduction is not lower than the same level of evaluation group, 3 and above the reporting enterprise review group generated by the average price reduction;
enterprise with a higher score is determined to be the first enterprise to be selected, the enterprise with a lower score accepts the selected price, and the second-place enterprise is selected, and does not accept the same as giving up.
Enterprises with higher scores give up, enterprises with lower scores meet the following two conditions to determine the enterprise to be selected, and if they do not reach: (1) the price drop is not lower than the average price of the selected price generated by the evaluation group of 3 or more reporting enterprises;
(3) to declare the enterprise 1 of the evaluation group expert group bargaining to determine the proposed enterprise.
Accept one of the following price reductions, for the evaluation group to select enterprises, do not accept the same as abandonment: (1) the same level of evaluation group, 3 or more reporting enterprises evaluation group generated by the average decline in the average price of the selected;
Whether it is national or local collection, it is necessary for pharmaceutical companies to accurately prejudge policies and market trends, timely and rational decision-making will become the domestic generic drug companies in the future market competition, price game required courses, and careful study of collection documents, is the first step.
, that is to say, there are already a number of pharmaceutical companies, put in tight price estimates and quotations went.
: Shandong Province drug concentrated with the purchase of varieties list.